Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis

Abstract

Background and objectives:

The Symbol Digit Modalities Test (SDMT) shows advantages over the Paced Auditory Serial Addition Test (PASAT) as a cognitive test in patients with multiple sclerosis (MS). To determine which of these tests is most valid and reliable over time as an indicator of the cognitive state of MS patients, long-term test results of both tests were compared in relation to scores of the Brief Repeatable Battery of Neuropsychological tests (BRBN).

Methods:

For 485 MS patients visiting the VU University Medical Center Amsterdam for different research projects, a total number of 1078 visits with BRBN (including PASAT and SDMT) was planned. Observed and model-based correlations were used to calculate the construct validity of the SDMT and PASAT 3 seconds test (PASAT3) by comparing correlations with the BRBN-sumscore. The test-retest reliability of each test was also computed.

Results:

For the construct validity, higher correlations were found between SDMT and BRBN compared to PASAT3 and BRBN, especially for the model-based correlations at baseline. The reliability of the measurements was good for all instruments, with the highest coefficients for the SDMT.

Conclusion:

As a single assessment tool for cognition in MS, the SDMT is more valid and reliable compared to PASAT3.

Keywords

Multiple sclerosis PASAT SDMT BRBN MSFC cognition

Get full access to this article

View all access options for this article.

References

Rao

Leo

Ellington

. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692–696.

Chiaravalloti

DeLuca

. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139–1151.

Rogers

Panegyres

. Cognitive impairment in multiple sclerosis: Evidence-based analysis and recommendations. J Clin Neurosci 2007; 14: 919–927.

Amato

Portaccio

Goretti

. Cognitive impairment in early stages of multiple sclerosis. Neurol Sci 2010; 31: S211–S214.

Possa

. Neuropsychological measures in clinical practice. Neurol Sci 2010; 31: S219–S222.

Feuillet

Reuter

Audoin

. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2007; 13: 124–127.

Gronwall

. Paced auditory serial-addition task: A measure of recovery from concussion. Percept Mot Skills 1977; 44: 367–373.

Cutter

Baier

Rudick

. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122 (Pt 5): 871–882.

Rao

in collaboration with the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.

10.

Rao

. A manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Unpublished manuscript, Section of Neuropsychology, Department of Neurology, Medical College of Wisconsin, 1991.

11.

Fisk

Archibald

. Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis. J Int Neuropsychol Soc 2001; 7: 363–372.

12.

Tombaugh

. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006; 21: 53–76.

13.

Smith

. Symbol digit modalities test. Los Angeles: Western Psychological Services, 1982.

14.

Bever

Jr Grattan

Panitch

. The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: A preliminary serial study. Mult Scler 1995; 1: 165–169.

15.

Parmenter

Weinstock-Guttman

Garg

. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test. Mult Scler 2007; 13: 52–57.

16.

Langdon

Amato

Boringa

. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18: 891–898.

17.

Deloire

Bonnet

Salort

. How to detect cognitive dysfunction at early stages of multiple sclerosis? Mult Scler 2006; 12: 445–452.

18.

Benedict

Duquin

Jurgensen

. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler 2008; 14: 940–946.

19.

Drake

Weinstock-Guttman

Morrow

. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: Replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010; 16: 228–237.

20.

Benedict

Wahlig

Bakshi

. Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231: 29–34.

21.

Strober

Englert

Munschauer

. Sensitivity of conventional memory tests in multiple sclerosis: Comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009; 15: 1077–1084.

22.

Kurtzke

. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

23.

Morrow

O’Connor

Polman

. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult Scler 2010; 16: 1385–1392.

24.

Buschke

Fuld

. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24: 1019–1025.

25.

Barbizet

Cany

. Clinical and psychometrical study of a patient with memory disturbances. Int J Neurol 1968; 7: 44–54.

26.

Sepulcre

Vanotti

Hernández

. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Mult Scler 2006; 12: 187–195.

27.

Boringa

Lazeron

Reuling

. The brief repeatable battery of neuropsychological tests: Normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001; 7: 263–267.

28.

Vangeneugden

Laenen

Geys

. Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements. Control Clin Trials 2004; 25: 13–30.

29.

Nunnally

Bernstein

. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994.

30.

Skrondal

Rabe-Hesketh

. Generalized latent variable modeling: Multilevel, longitudinal and structural equation models. Boca Raton, FL: Chapman & Hall/CRC, 2004.

31.

Williams

O’Rourke

Hutchinson

. The Face-Symbol Test and the Symbol-Digit Test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis. Mult Scler 2006; 12: 599–604.

32.

Brochet

Deloire

Bonnet

. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Mult Scler 2008; 14: 1242–1249.

33.

Benedict

Amato

Boringa

. Brief International Cognitive Assessment for MS (BICAMS): International standards for validation. BMC Neurol 2012; 12: 55.

34.

Lord

Novick

. Statistical theories of mental test scores. Reading, MA: Addison-Wesley, 1968.

35.

Nunnally

. Psychometric theory. New York: McGraw-Hill, 1967.

36.

Jacobson

Truax

. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12–19.

37.

SAS Institute Inc. SAS/STAT user’s guide (version 9.2). Cary, NC: SAS Institute Inc, 2008.

38.

Hoef

JMV

. Who invented the delta method? Am Stat 2012: 66: 124–127.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.56 MB